IDO1 and neoplasm: The components of the designed UCMS@Pep-aPDL1 were shown to be capable of potentiated local and systemic anti-tumor immunity through stimulating the killing of IDO-expressed tumor cells, inducing immunogenic cell death, and promoting the infiltration of effector T-cell (Wang et al., 2021; Chen et al., 2022).